• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生活质量对房颤患者价值的预后意义。

The prognostic value of quality of life in atrial fibrillation on patient value.

机构信息

Máxima Medical Center, Veldhoven, The Netherlands.

Netherlands Heart Network, Michelangelolaan 2, Eindhoven, 5623 EJ, The Netherlands.

出版信息

Health Qual Life Outcomes. 2023 Apr 5;21(1):33. doi: 10.1186/s12955-023-02112-2.

DOI:10.1186/s12955-023-02112-2
PMID:37016364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10074786/
Abstract

BACKGROUND

In this study, the prognostic value of AF-related quality of life (AFEQT) at baseline on Major Adverse Cardiovascular Events (MACE) and improvement of perceived symptoms (EHRA) was assessed. Furthermore, the relationship between QoL and AF-related hospitalizations was assessed.

METHODS

A cohort of AF-patients diagnosed between November 2014 and October 2019 in four hospitals embedded within the Netherlands Heart Network were prospectively followed for 12 months. MACE was defined as stroke, myocardial infarction, heart failure and/or mortality. Subsequently, MACE, EHRA score improvement and AF-related hospitalizations between baseline and 12 months of follow-up were recorded.

RESULTS

In total, 970 AF-patients were available for analysis. In analyses with patients with complete information on the confounder subset 36/687 (5.2%) AF-patients developed MACE, 190/432 (44.0%) improved in EHRA score and 189/510(37.1%) were hospitalized during 12 months of follow-up. Patients with a low AFEQT score at baseline more often developed MACE (OR(95%CI): 2.42(1.16-5.06)), more often improved in EHRA score (OR(95%CI): 4.55(2.45-8.44) and were more often hospitalized (OR(95%CI): 4.04(2.22-7.01)) during 12 months post diagnosis, compared to patients with a high AFEQT score at baseline.

CONCLUSIONS

AF-patients with a lower quality of life at diagnosis more often develop MACE, more often improve on their symptoms and also were more often hospitalized, compared to AF-patients with a higher quality of life. This study highlights that the integration of patient-reported outcomes, such as quality of life, has the potential to be used as a prognostic indicator of the expected disease course for AF.

摘要

背景

在这项研究中,评估了基线时与房颤相关的生活质量(AFEQT)对主要心血管不良事件(MACE)和感知症状改善(EHRA)的预后价值。此外,还评估了生活质量与房颤相关住院之间的关系。

方法

在荷兰心脏网络内的四家医院中,对 2014 年 11 月至 2019 年 10 月期间确诊的房颤患者进行前瞻性随访 12 个月。MACE 的定义为中风、心肌梗死、心力衰竭和/或死亡。随后,记录基线和 12 个月随访期间的 MACE、EHRA 评分改善和房颤相关住院情况。

结果

共 970 名房颤患者可进行分析。在对混杂因素子集信息完整的患者进行分析时,36/687(5.2%)名房颤患者发生 MACE,190/432(44.0%)名患者 EHRA 评分改善,189/510(37.1%)名患者在 12 个月随访期间住院。基线时 AFEQT 评分较低的患者发生 MACE 的可能性更高(OR(95%CI):2.42(1.16-5.06)),EHRA 评分改善的可能性更高(OR(95%CI):4.55(2.45-8.44)),并且在诊断后 12 个月内住院的可能性更高(OR(95%CI):4.04(2.22-7.01)),与基线时 AFEQT 评分较高的患者相比。

结论

与生活质量较高的房颤患者相比,诊断时生活质量较低的房颤患者更常发生 MACE,更常改善症状,也更常住院。这项研究强调,整合患者报告的结果,如生活质量,有可能成为房颤预期疾病过程的预后指标。

相似文献

1
The prognostic value of quality of life in atrial fibrillation on patient value.生活质量对房颤患者价值的预后意义。
Health Qual Life Outcomes. 2023 Apr 5;21(1):33. doi: 10.1186/s12955-023-02112-2.
2
Age-dependency of EHRA improvement based on quality of life at diagnosis of atrial fibrillation.基于房颤诊断时生活质量的欧洲心律协会(EHRA)改善情况的年龄依赖性
J Arrhythm. 2022 Jan 10;38(1):50-57. doi: 10.1002/joa3.12671. eCollection 2022 Feb.
3
Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).心房颤动症状、生活质量与患者预后之间的关联:心房颤动更明智治疗结局登记研究(ORBIT-AF)的结果
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402. doi: 10.1161/CIRCOUTCOMES.114.001303. Epub 2015 Jun 9.
4
The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.欧洲心律协会房颤症状分类:通过简单修改进行验证与改进
Europace. 2014 Jul;16(7):965-72. doi: 10.1093/europace/eut395. Epub 2014 Feb 16.
5
Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).队列特征描述:新诊断心房颤动患者的特征和生活质量测量-日本庆应义塾大学医院间心血管研究-心房颤动(KiCS-AF)。
BMJ Open. 2019 Dec 18;9(12):e032746. doi: 10.1136/bmjopen-2019-032746.
6
Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.阵发性和持续性心房颤动消融的结果与肺静脉消融导管 GOLD 定频相控射频消融导管:来自 GOLD 心房颤动登记研究的生活质量和 12 个月疗效结果。
Europace. 2020 Jun 1;22(6):888-896. doi: 10.1093/europace/euaa042.
7
Baseline Health Status and its Association With Subsequent Cardiovascular Events in Patients With Atrial Fibrillation.基线健康状况及其与房颤患者后续心血管事件的关系。
JACC Clin Electrophysiol. 2023 Sep;9(9):1934-1944. doi: 10.1016/j.jacep.2023.05.037. Epub 2023 Jul 26.
8
Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life Score.定义心房颤动对生活质量评分影响的临床重要差异。
Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005358. doi: 10.1161/CIRCOUTCOMES.118.005358.
9
Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.评估日本心房颤动患者初始症状负担、应用治疗策略和生活质量的性别差异。
JAMA Netw Open. 2019 Mar 1;2(3):e191145. doi: 10.1001/jamanetworkopen.2019.1145.
10
Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?解读心房颤动患者生活质量的变化:多大的变化才具有临床意义?
Am Heart J. 2013 Aug;166(2):381-387.e8. doi: 10.1016/j.ahj.2013.04.015. Epub 2013 Jul 1.

本文引用的文献

1
Importance and Assessment of Quality of Life in Symptomatic Permanent Atrial Fibrillation: Patient Focus Groups from the RATE-AF Trial.症状性永久性心房颤动中生活质量的重要性和评估:来自 RATE-AF 试验的患者焦点小组。
Cardiology. 2020;145(10):666-675. doi: 10.1159/000511048. Epub 2020 Aug 28.
2
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
3
Evaluation of a pharmacist-led shared decision-making in atrial fibrillation and patients' satisfaction-a before and after pilot study.评价药师主导的心房颤动患者共同决策和患者满意度的试点研究:一项前后对照研究。
Ir J Med Sci. 2021 May;190(2):819-824. doi: 10.1007/s11845-020-02343-y. Epub 2020 Aug 17.
4
Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models.预测二级预防中的主要不良心血管事件:风险预测模型的系统评价和荟萃分析方案。
BMJ Open. 2020 Jul 27;10(7):e034564. doi: 10.1136/bmjopen-2019-034564.
5
Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.心房颤动患者症状和生活质量与结局的相关性。
Heart. 2020 Dec;106(23):1847-1852. doi: 10.1136/heartjnl-2019-316314. Epub 2020 Mar 31.
6
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.《2019年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
7
Assessment of Atrial Fibrillation-Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?心房颤动消融前后心房颤动特异性症状的评估:患者和医生对症状缓解的感知是否存在差异?
JACC Clin Electrophysiol. 2017 Oct;3(10):1168-1176. doi: 10.1016/j.jacep.2017.04.003. Epub 2017 Jun 28.
8
Patient-Reported Outcomes - Are They Living Up to Their Potential?患者报告的结局——它们是否发挥了自身潜力?
N Engl J Med. 2017 Jul 6;377(1):6-9. doi: 10.1056/NEJMp1702978.
9
The cost of atrial fibrillation in Italy: a five-year analysis of healthcare expenditure in the general population. From the Italian Survey of Atrial Fibrillation Management (ISAF) study.意大利房颤的成本:对普通人群医疗支出的五年分析。来自意大利房颤管理调查(ISAF)研究。
Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):175-183.
10
Patient factors associated with quality of life in atrial fibrillation.与心房颤动患者生活质量相关的因素
Am Heart J. 2016 Dec;182:135-143. doi: 10.1016/j.ahj.2016.08.003. Epub 2016 Aug 19.